Evaluation of plasma phosphorylated tau217 for differentiation between alzheimer disease and frontotemporal lobar degeneration subtypes among patients with corticobasal syndrome

HIGHLIGHTS

  • who: American Medical Association from the cognitively normal control individuals (n, ) were evaluated at University of have published the research: Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome, in the Journal: (JOURNAL)

SUMMARY

    @@

ACRONYMS

LAY DEFINITIONS

  • Syndrome: A characteristic symptom complex.
  • Patients: Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.
  • Plasma: Plasma is one of the four fundamental states of matter, the . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?